[Congressional Record Volume 169, Number 109 (Thursday, June 22, 2023)]
[Senate]
[Page S2238]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




    SENATE RESOLUTION 270--DESIGNATING JULY 15, 2023, AS ``NATIONAL 
                     LEIOMYOSARCOMA AWARENESS DAY''

  Ms. STABENOW submitted the following resolution; which was referred 
to the Committee on the Judiciary:

                              S. Res. 270

       Whereas leiomyosarcoma is a malignant sarcoma subtype, one 
     of 70 to 100 such subtypes, that arises in smooth muscle and 
     has several subtypes itself due to its vascularity and bone 
     invasion;
       Whereas leiomyosarcoma is designated by the National 
     Institutes of Health as a rare form of cancer;
       Whereas leiomyosarcoma is largely resistant to standard 
     chemotherapy treatments, radiation treatments, and 
     immunotherapy trials, with 40-year-old chemotherapy 
     treatments still in use;
       Whereas leiomyosarcoma affects all age groups, including 
     children, young adults, the middle-aged, and the elderly, and 
     all genders;
       Whereas leiomyosarcoma is diagnosed in more than 2,000 
     individuals in the United States each year;
       Whereas, with respect to leiomyosarcoma, research and 
     clinical trials remain complicated and extremely costly due 
     to the difficulty of recruiting patients;
       Whereas survival and longevity for individuals with 
     leiomyosarcoma has not significantly improved for at least 30 
     years;
       Whereas multidisciplinary care coordination teams, because 
     of their expertise and experience, are critical to the health 
     of leiomyosarcoma patients;
       Whereas researchers continue to strive to improve quality 
     of life for leiomyosarcoma patients, improve outcomes in 
     clinical trials, and promote enhanced survivorship; and
       Whereas increased education and awareness about sarcoma and 
     leiomyosarcoma will contribute to the well-being of the 
     communities of the United States: Now, therefore, be it
       Resolved, That the Senate--
       (1) designates July 15, 2023, as ``National Leiomyosarcoma 
     Awareness Day'';
       (2) recognizes the challenges faced by leiomyosarcoma 
     patients; and
       (3) commends the dedication of organizations, volunteers, 
     researchers, and caregivers across the United States working 
     to improve the quality of life of leiomyosarcoma patients and 
     their families.

                          ____________________